ProtoKinetix (OTCMKTS:PKTX) Stock Price, News, Analysis & History

$0.05 0.00 (0.00 %)
(As of 03/22/2018 04:00 PM ET)
Previous Close$0.05
Today's Range$0.05 - $0.05
52-Week Range$0.04 - $0.12
Volume37,646 shs
Average Volume59,597 shs
Market Capitalization$14.27 million
P/E Ratio-5.30
Dividend YieldN/A

About ProtoKinetix (OTCMKTS:PKTX)

ProtoKinetix, Incorporated is a research and development-stage bio-technology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). AFGP is a compound produced by fish, insects, reptiles, bacteria and plants that enable survival in freezing temperatures. HealthCare Applications of AAGP fall into various categories, such as harvesting, storage and transplanting cells, tissues and organs, and treatments for conditions and diseases caused by stress factors, including ultraviolet (UV) radiation, oxidation and inflammation. As of December 31, 2016, the Company had no revenue.

Receive PKTX News and Ratings via Email

Sign-up to receive the latest news and ratings for PKTX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-5.3
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($0.01)
Net IncomeN/A
Net MarginsN/A
Return on Equity-209.79%
Return on Assets-205.28%


Outstanding Shares245,950,000

ProtoKinetix (OTCMKTS:PKTX) Frequently Asked Questions

What is ProtoKinetix's stock symbol?

ProtoKinetix trades on the OTCMKTS under the ticker symbol "PKTX."

Who are some of ProtoKinetix's key competitors?

Who are ProtoKinetix's key executives?

ProtoKinetix's management team includes the folowing people:

  • Clarence E. Smith, President, Chief Executive Officer, Director (Age 50)
  • Michael Richard Guzzetta, Chief Financial Officer (Age 60)
  • Edward P. McDonough, Director (Age 63)

Has ProtoKinetix been receiving favorable news coverage?

Headlines about PKTX stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ProtoKinetix earned a coverage optimism score of 0.17 on Accern's scale. They also gave news coverage about the company an impact score of 46.96 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are ProtoKinetix's major shareholders?

ProtoKinetix's stock is owned by a number of of institutional and retail investors. Top institutional investors include SMITH CLARENCE EDWARD (27.16%), YOUNG LACHLAN GRANT (10.40%) and YOUNG LACHLAN GRANT (10.40%). Company insiders that own ProtoKinetix stock include Clarence Edward Smith and Susan Marie Woodward. View Institutional Ownership Trends for ProtoKinetix.

How do I buy shares of ProtoKinetix?

Shares of PKTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProtoKinetix's stock price today?

One share of PKTX stock can currently be purchased for approximately $0.05.

How big of a company is ProtoKinetix?

ProtoKinetix has a market capitalization of $14.27 million.

How can I contact ProtoKinetix?

ProtoKinetix's mailing address is 412 Mulberry St, MARIETTA, OH 45750-2016, United States. The company can be reached via phone at +1-304-2995070.

MarketBeat Community Rating for ProtoKinetix (PKTX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about ProtoKinetix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ProtoKinetix (OTCMKTS:PKTX) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


ProtoKinetix (OTCMKTS:PKTX) Earnings History and Estimates Chart

Earnings by Quarter for ProtoKinetix (OTCMKTS:PKTX)

ProtoKinetix (OTCMKTS PKTX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/12/2017Q1 2017($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


ProtoKinetix (OTCMKTS:PKTX) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for ProtoKinetix (OTCMKTS:PKTX)

No dividend announcements for this company have been tracked by

Insider Trades

ProtoKinetix (OTCMKTS PKTX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for ProtoKinetix (OTCMKTS:PKTX)
Insider Trades by Quarter for ProtoKinetix (OTCMKTS:PKTX)

ProtoKinetix (OTCMKTS PKTX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2018Clarence Edward SmithCEOBuy2,359,240$0.05$117,962.00View SEC Filing  
2/6/2017Clarence Edward SmithCEOBuy750,000$0.04$30,000.0053,820,500View SEC Filing  
2/6/2017Susan Marie WoodwardCFOBuy250,000$0.04$10,000.00250,000View SEC Filing  
12/20/2016Clarence Edward SmithCEOBuy4,000,000$0.04$160,000.0053,070,500View SEC Filing  
11/4/2016Clarence Edward SmithCEOBuy1,250,000$0.04$50,000.0045,570,500View SEC Filing  
9/23/2016Clarence Edward SmithCEOBuy321,263$0.06$19,275.7843,820,500View SEC Filing  
9/15/2016Clarence Edward SmithCEOBuy1,595,553$0.04$63,822.1243,820,500View SEC Filing  
8/25/2016Clarence Edward SmithCEOBuy90,753$0.05$4,537.6541,320,500View SEC Filing  
7/7/2016Clarence Edward SmithCEOBuy90,000$0.06$5,400.00View SEC Filing  
7/1/2016Clarence Edward SmithCEOBuy1,900,000$0.04$76,000.00View SEC Filing  
6/24/2016Clarence Edward SmithCEOBuy175,000$0.06$10,500.0043,092,157View SEC Filing  
6/16/2016Clarence Edward SmithCEOBuy780,000$0.04$31,200.0042,152,157View SEC Filing  
5/25/2016Clarence Edward SmithCEOBuy100,000$0.06$6,000.0042,072,157View SEC Filing  
5/18/2016Clarence Edward SmithCEOBuy145,000$0.07$10,150.0041,919,157View SEC Filing  
5/11/2016Clarence Edward SmithCEOBuy173,380$0.06$10,402.8041,777,157View SEC Filing  
5/3/2016Clarence Edward SmithCEOBuy416,000$0.06$24,960.0041,365,677View SEC Filing  
4/28/2016Clarence Edward SmithCEOBuy214,646$0.05$10,732.3040,109,631View SEC Filing  
4/25/2016Clarence Edward SmithCEOBuy402,631$0.04$16,105.2440,714,781View SEC Filing  
3/19/2015Clarence Edward SmithCEOBuy1,500,000$0.05$75,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


ProtoKinetix (OTCMKTS PKTX) News Headlines


SEC Filings

ProtoKinetix (OTCMKTS:PKTX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


ProtoKinetix (OTCMKTS PKTX) Stock Chart for Thursday, March, 22, 2018

Loading chart…

This page was last updated on 3/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.